Baciclox logo

Baciclox – Alembic Pharmaceuticals

Registered App ID 2148843 Class 5 Device

Trademark information

IP India · live record
Application ID
2148843
Status
Registered
Sub status
—
Date of application
24 May 2011
Classes
5
Type
Device
Proprietor
Alembic Pharmaceuticals Public Alembic Pharmaceuticals Ltd., Alembic Road, Vadodara 390 003
Attorney
Nanavati & Nanavati Advocates[2789]7th Floor, Corporate House, Sarkhej Gandhinagar Highway, Judges Bunglows Cross Road, Bodakdev, Ahmedabad 380054, Gujarat
State
Gujarat
Filing mode
Branch Office
IP office
Ahmedabad
Used since
01 July 1988
Valid / upto
24 May 2031

Goods & services

Class 5

Class 5PHARMACEUTICAL AND MEDICINAL PREPARATIONS FOR TREATMENT OF GRAM POSITIVE AND GRAM NEGATIVE INFECTIONS AND BACTERIA ATTACK.

PR details

ALEMBIC PHARMACEUTICALS LIMITED, Alembic Pharmaceuticals Ltd., Alembic Road, Vadodara 390 003, AN INDIAN COMPANY REGISTERED UNDER THE PROVISIONS OF COMPANIES ACT, 1956, MANUFACTURERS AND MERCHANTS, (Body Incorporate)

PURSUANT TO A REQUEST ON FORM TM-50 DATED 02/02/2016 AND ORDER THEREON DATED 28/03/2016 THE ADDRESS FOR SERVICE IS ALTERED TO NANAVATI & NANAVATI ADVOCATES , 7TH FLOOR, CORPORATE HOUSE, SARKHEJ - GANDHINAGAR HIGHWAY, JUDGES BUNGLOWS CROSS ROAD, BODAKDEV, AHMEDABAD - 380054, GUJARAT

REGISTRATION RENEWED FOR A PERIOD OF 10 YEARS FROM 24/05/2021 ADVERTISED IN JOURNAL NO. 2003

Mark image

Device

Uploaded documents

Sign in to open
1 General Power of Attorney 05 May 2011
2 Additional Representation Sheet 24 May 2011
3 TM-1 24 May 2011
4 Other Documents 08 Aug 2012
5 Journal Copy 25 Apr 2013
6 TM-R(RENEWAL OF TRADE MARK) 21 May 2021

Correspondence and notices

1 O3 NOTICE 11121856 · 5123381 17 Feb 2021
2 RENEWAL INTIMATION LETTER 11549820 24 May 2021

Frequently asked questions

Baciclox was applied for on 24 May 2011.

The application was filed by Alembic Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Baciclox is 2148843.

Trademark attorney Nanavati & Nanavati Advocates.